CD4 and cancer: Immunodeficiency in advanced cancer has been well documented and there is a significant trend of decreasing functional T cell populations (including CD4, CD8, CD4:CD8 ratio and naïve T cells) with cancer progression: this is associated with increased morbidity and mortality [56].